BRIMAR THERAPEUTICS

Developed Blood Substitute already cleared for K-9 by FDA.

Facebook Twitter LinkedIn

BriMar Therapeutics has developed, patented, tested and has FDA CLEARANCE to market a Bloodless and animal protein clear Blood Substitute. This first clearance is approved for animals. K-9 has been a major part of testing. 

Fundraise Details

This section is only visible to registered investors. Log in or register as an accredited investor to view.

Ready to Ask For Funding for your company?

Post a Funding Request